Stock Price
2.61
Daily Change
0.04 1.56%
Monthly
-2.61%
Yearly
-44.35%
Q2 Forecast
2.42

MannKind reported $695M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Karyopharm Therapeutics USD 652M 517M Apr/2026
MacroGenics USD 102M 4M Dec/2025
MannKind USD 1.74B 93M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Xencor USD 1.09B 256M Dec/2025